Orient Bio Inc
KRX:002630

Watchlist Manager
Orient Bio Inc Logo
Orient Bio Inc
KRX:002630
Watchlist
Price: 602 KRW -2.9% Market Closed
Market Cap: 71.4B KRW

EV/EBITDA
Enterprise Value to EBITDA

-16
Current
9.7
Median
19.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-16
=
Enterprise Value
42.4B KRW
/
EBITDA
-2.7B KRW
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A